Intervention Review

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement

  1. Carlos A Salazar1,*,
  2. German Malaga2,
  3. Giuliana Malasquez2

Editorial Group: Cochrane Peripheral Vascular Diseases Group

Published Online: 14 APR 2010

Assessed as up-to-date: 11 MAR 2010

DOI: 10.1002/14651858.CD005981.pub2


How to Cite

Salazar CA, Malaga G, Malasquez G. Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement. Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No.: CD005981. DOI: 10.1002/14651858.CD005981.pub2.

Author Information

  1. 1

    Universidad Peruana Cayetano Heredia, Department of Medicine, Lima, Peru

  2. 2

    Universidad Peruana Cayetano Heredia, Lima, Peru

*Carlos A Salazar, Department of Medicine, Universidad Peruana Cayetano Heredia, Avenida Honorio Delgado 430, San Martin de Porres, Lima, Peru. caso90@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 14 APR 2010

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jenson C. S. Mak, Marlene Fransen, Matthew Jennings, Lynette March, Rajat Mittal, Ian A. Harris, Evidence-based review for patients undergoing elective hip and knee replacement, ANZ Journal of Surgery, 2014, 84, 1-2
  2. 2
    Luciano A. Sposato, Osvaldo Fustinoni, Neurologic Aspects of Systemic Disease Part III, 2014,

    CrossRef

  3. 3
    J. C. S. Mak, I. A. Harris, A significant gap still exists between clinical guidelines and practice for hip and knee arthroplasty, Internal Medicine Journal, 2013, 43, 12
  4. 4
    Nathan P. Clark, Stephanie E. Cho, Thomas Delate, Daniel M. Witt, Thromboembolic and bleeding outcomes of low-intensity warfarin thromboprophylaxis following elective total hip arthroplasty, Thrombosis Research, 2013, 131, 5, 390

    CrossRef

  5. 5
    Judy W.M. Cheng, Huyen Vu, Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for the Management of Thromboembolic Disorders, Clinical Therapeutics, 2012, 34, 4, 766

    CrossRef

  6. 6
    Stephan H. Schirmer, Magnus Baumhäkel, Hans-Ruprecht Neuberger, Stefan H. Hohnloser, Isabelle C. van Gelder, Gregory Y.H. Lip, Michael Böhm, Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation, Journal of the American College of Cardiology, 2010, 56, 25, 2067

    CrossRef

  7. 7
    The Cochrane Database of Systematic Reviews, Issue 4, 2010, Journal of Evidence-Based Medicine, 2010, 3, 2
  8. 8
    Yanzhi Song, Liu Liu, Xiaodong Li, Jie Ding, Pentasaccharides for the prevention of venous thromboembolism, The Cochrane Library,